Related by context. Frequent words. (Click for all words.) 69 Cetrorelix 67 phase IIb clinical 67 Dasatinib 66 Pivotal Phase III 66 forodesine 66 Pirfenidone 65 Pivotal Phase 65 Phase III Trial 64 Panzem R 64 squalamine 64 Laquinimod 64 MKC# 64 Pivotal Trial 64 INCB# [001] 64 Clinical Trial Results 64 mRCC 64 Phase III Clinical Trial 64 Amrubicin 63 metastatic castration resistant 63 elotuzumab 63 APTIVUS 63 HGS ETR1 63 Patient Enrollment 63 anticancer compound 63 gastrointestinal stromal tumors GIST 63 metastatic hormone refractory 63 Carfilzomib 62 refractory chronic lymphocytic 62 Lu AA# 62 Adalimumab 62 muraglitazar 62 Mipomersen 62 Monotherapy 62 Chronic Hepatitis C 62 Natalizumab 62 PEG SN# 62 registrational trial 62 Cethromycin 62 Irinotecan 62 Metastatic Melanoma 62 Sorafenib 62 Phase IIIb 62 IMC A# 62 II Clinical Trial 62 ixabepilone 62 Tesetaxel 61 Erlotinib 61 NVA# 61 Benign Prostatic Hyperplasia 61 liposomal formulation 61 metastatic renal cell carcinoma 61 Drug Candidate 61 enzastaurin 61 castration resistant prostate cancer 61 Epratuzumab 61 GSK# [001] 61 Vandetanib 61 double blinded placebo 61 Proxinium TM 61 Metastatic Colorectal Cancer 61 BAY #-# 61 Fibrillex TM 61 darapladib 61 BZL# 61 axitinib 61 Ixempra 61 Overactive Bladder 61 Diabetic Macular Edema 61 Desmoteplase 61 Initiate Phase 61 Phase Ib clinical 61 ATL# [001] 61 PSN# [002] 61 Clofarabine 61 Alemtuzumab 61 GVAX 61 non alcoholic steatohepatitis 61 CCX# 60 Gastric Cancer 60 Phase IIB 60 Zolinza 60 phase IIa 60 phase IIa clinical 60 abiraterone acetate 60 IMC #B 60 Recombinant Human 60 Asentar 60 Completes Enrollment 60 secondary hyperparathyroidism 60 placebo controlled clinical 60 investigational oral 60 luteinizing hormone releasing 60 Newly Diagnosed 60 ISTODAX 60 pheochromocytoma 60 Phase 2a trial 60 refractory multiple myeloma 60 Traficet EN 60 cangrelor 60 R sorafenib tablets 60 Chronic Lymphocytic Leukemia